Gennex Laboratories declares Unaudited Q2 FY27 Results

Gennex Laboratories Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, along with the Statement of Assets and Liabilities and Statement of Cash Flows. The company also announced the reconstitution of its Audit Committee, Nomination & Remuneration Committee, and Stakeholders Relationship Committee, and the dissolution of the Rights Issue Committee. The Board meeting was held on November 14, 2026.